GGrantIndex
← Search

Clinical Protocol and Data Management/Clinical Trials Office (Core-015)

$7,969P30FY2018CANIH

Vanderbilt University Medical Center, Nashville TN

Investigators

Linked publications, trials & patents

Trial NCT07016399Trial NCT06593106Trial NCT05501665Trial NCT05361720Trial NCT04765072Trial NCT02702310Trial NCT02685631Trial NCT02677883Trial NCT02676752Trial NCT02672475Trial NCT02658487Trial NCT02600533Trial NCT02489422Trial NCT02480114Trial NCT02457910Trial NCT02448225Trial NCT02440737Trial NCT02374931Trial NCT02359851Trial NCT02324881Trial NCT02296112Trial NCT02269111Trial NCT02240381Trial NCT02236546Trial NCT02170272Trial NCT02151539Trial NCT02148406Trial NCT01996527Trial NCT01928160Trial NCT01901367Trial NCT01660971Trial NCT01230515Trial NCT01198535Trial NCT01141218Trial NCT01098669Trial NCT01098643Trial NCT01096407Trial NCT01096394Trial NCT01096381Trial NCT01077440Trial NCT01031446Trial NCT01013506Trial NCT01009931Trial NCT01007422Trial NCT00993694Trial NCT00993135Trial NCT00987766Trial NCT00984542Trial NCT00984490Trial NCT00983268Trial NCT00957736Trial NCT00949052Trial NCT00930930Trial NCT00900406Trial NCT00900003Trial NCT00899769Trial NCT00899626Trial NCT00899457Trial NCT00899301Trial NCT00899028Trial NCT00898742Trial NCT00898638Trial NCT00898430Trial NCT00898313Trial NCT00897988Trial NCT00897832Trial NCT00897793Trial NCT00897650Trial NCT00897468Trial NCT00897403Trial NCT00897117Trial NCT00896948Trial NCT00896675Trial NCT00892801Trial NCT00875238Trial NCT00840814Trial NCT00837876Trial NCT00835679Trial NCT00801346Trial NCT00765245Trial NCT00755040Trial NCT00675636Trial NCT00670644Trial NCT00670605Trial NCT00670046Trial NCT00666211Trial NCT00656604Trial NCT00653250Trial NCT00651976Trial NCT00651716Trial NCT00647218Trial NCT00626873Trial NCT00625417Trial NCT00625066Trial NCT00616590Trial NCT00601991Trial NCT00573404Trial NCT00550537Trial NCT00544648Trial NCT00533884

Abstract

CORE 015: Clinical Protocol and Data Management; Data and Safety Monitoring; Inclusion of Women, Minorities and Children Project Summary The VICC Clinical Trials Shared Resource (CTSR) serves as a comprehensive resource to support adult and pediatric clinical research of the Cancer Center members ensuring timely and accurate protocol management. The CTSR continuously evaluates its systems to respond to the ever-changing landscape of clinical research now emphasizing increasingly complex genotype-driven trials. The CTSR assists investigators in all portions of clinical trial (CT) management, including financial, regulatory, data, screening, nursing management, imaging support and sample processing. The CTSR has dedicated budget and contracting analysts to negotiate budgets and contracts; regulatory staff to assist in preparation of all regulatory documents, including submissions to the Scientific Review Committee (SRC), the IRB, the Clinical Research Center (CRC), and IND submissions to the FDA. Scientific review, budgeting and contracting and regulatory submission occur in parallel, leading to an average time to final contract and Institutional Review Board (IRB) approval of 94 calendar days. Research staff report protocol deviations and Serious Adverse Event (SAE), while providing a robust data management team for all CTs. Additionally, Research Nurses support Investigators in the day-to-day protocol implementation, including consenting and patient visits. In response to the increasing complexity of biospecimen requirements, the Clinical Trial Processing Laboratory underwent a major redesign and is now processing more than 1100 specimens per month. The CTSR assists in patient accrual by screening new patients for CT eligibility and interacting with referring physicians to identify potential studies for them. VICC places highest priority on ensuring the safety of our patients participating in clinical research and provides a compliance team who performs monitoring and internal audits as outlined by the Data and Safety Monitoring Committee (DSMC). Additionally, CTSR provides investigator support for study registration and results reporting to ClinicalTrials.gov and the NCI Clinical Trials Reporting Program. Continuing its commitment to increasing diversity in clinical trials, VICC supported the recruitment of several key faculty whose work focuses on disparities and community engagement in clinical research. Since 2010, VICC sustained a 37% increase in accruals to interventional trials (699 to 961) and a 15% increase in therapeutic trials (581 to 666). Under the direction of the Medical Director, Vicki Keedy, MD, MSCI and the Director, Debra Wujcik, PhD, RN, the CTSR assists faculty in performing a large portfolio of CTs bringing innovative discoveries from the laboratory to clinical care.

View original record on NIH RePORTER →